Bailard, Inc. Ironwood Pharmaceuticals Inc Transaction History

Bailard, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	BUY	$11.05 - $12.72 $149,175 - $171,720	13,500 New	13,500 $156,000
Q4 2018 Feb 05, 2019	SELL	$7.8 - $16.13 $222,300 - $459,705	-28,500 Closed	0 $0
Q2 2018 Aug 08, 2018	BUY	$11.83 - $16.2 $65,065 - $89,100	5,500 Added 23.91%	28,500 $545,000
Q4 2017 Feb 08, 2018	BUY	$12.16 - $14.58 $279,680 - $335,340	23,000	23,000 $0

237

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $679M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

Stay updated on Bailard, Inc. with notifications on news.